Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

Conditions

• Solid Tumors
• Lymphoma

Interventions

• DRUG: Alisertib
• DRUG: Esomeprazole
• DRUG: Rifampin

Sponsor

Millennium Pharmaceuticals, Inc.